Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - atogepantum - compresse - atogepantum 60 mg, copovidonum, tocofersolanum, mannitolum, cellulosum microcristallinum, natrii chloridum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, pro compresso corresp. natrium 31.48 mg. - migräneprophylaxe bei erwachsenen - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - venetoclaxum - compresse rivestite con film - venetoclaxum 10 mg, copovidonum k 28, polysorbatum 80, silica colloidalis anhydrica, calcii phosphas, natrii stearylis fumaras corresp. natrium 0.03 mg, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), pro compresso obducto. - chronisch lymphatische leukämie (cll), akute myeloische leukämie (aml) - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - venetoclaxum - compresse rivestite con film - venetoclaxum 50 mg, copovidonum k 28, polysorbatum 80, silica colloidalis anhydrica, calcii phosphas, natrii stearylis fumaras corresp. natrium 0.15 mg, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - chronisch lymphatische leukämie (cll), akute myeloische leukämie (aml) - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - venetoclaxum - compresse rivestite con film - venetoclaxum 100 mg, copovidonum k 28, polysorbatum 80, silica colloidalis anhydrica, calcii phosphas, natrii stearylis fumaras corresp. natrium 0.31 mg, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), pro compresso obducto. - chronisch lymphatische leukämie (cll), akute myeloische leukämie (aml) - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - linaclotidum - capsule - linaclotidum 0.29 mg, cellulosum microcristallinum, hypromellosum, calcii chloridum dihydricum, leucinum, kapselhülle: gelatina, e 172 (rubrum), e 171, e 172 (flavum), macrogolum 3350, drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, e 171, e 172 (nigrum), pro capsula. - trattamento sintomatico di moderata a grave reizkolon sindrome di stipsi negli adulti - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - ritonavirum - sirup - ritonavirum 600 mg, aromatica, saccharinum natricum, color.: e 110, excipiens ad solutionem pro 7.5 ml corresp. ethanolum 43.2 % v/v. - hiv-infektionen - synthetika human

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - palivizumabum - injektionspräparat - preparazione cryodesiccata: palivizumabum 73 mg, glycinum, histidinum, mannitolum, per il vetro. rilascio: acqua iniectabilia, per il vetro, corrisp. soluzione reconstituta 0,5 ml con palivizumabum 50 mg. - rsv-prophylaxe - biotechnologika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - palivizumabum - injektionspräparat - preparazione cryodesiccata: palivizumabum 122 mg, glycinum, histidinum, mannitolum, per il vetro. rilascio: acqua iniectabilia, per il vetro, corrisp. soluzione reconstituta 1 ml con palivizumabum 100 mg. - rsv-prophylaxe - biotechnologika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - paricalcitolum - capsule - paricalcitolum 1 µg antiox.: e 321, excipiens per la capsula. - behandlung des sekundären hyperparathyreoidismus ckd 3, 4 und 5 stufe - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - paricalcitolum - capsule - paricalcitolum 2 µg, antiox.: e 321, excipiens per la capsula. - behandlung des sekundären hyperparathyreoidismus ckd 3, 4 und 5 stufe - synthetika